Loading stock data...

Sastasundar Ventures Limited

NSE: SASTASUNDR BSE: SASTASUNDR

NSE
316.00 -3.55 (-1.11%)

Prev Close

319.55

Open Price

318.3

Volume

8,407

Today Low / High

310 / 319.89999

52 WK Low / High

205 / 342

Range

300 - 332

BSE
314.10 -6.05 (-1.89%)

Prev Close

320.15

Open Price

314.9

Volume

46

Today Low / High

311 / 317.8

52 WK Low / High

204.7 / 344.9

Range

298 - 330

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 316 (target range: 300 - 332), reflecting a change of -3.55 (-1.11094%). On the BSE, it is listed at 314.1 (target range: 298 - 330), showing a change of -6.05 (-1.88974%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

02 Jan 296.60 6.46%
01 Jan 298.25 -1.12%
31 Dec 303.10 -2.64%
30 Dec 301.80 -0.61%
29 Dec 301.25 -0.07%
26 Dec 304.30 -1.00%
24 Dec 308.00 -1.92%
23 Dec 299.30 2.39%
22 Dec 301.85 -0.10%
19 Dec 305.20 -0.44%
18 Dec 302.95 0.30%
17 Dec 303.55 -0.58%
16 Dec 301.00 0.47%
15 Dec 302.25 0.15%
12 Dec 301.65 -0.25%
11 Dec 302.25 -0.22%
10 Dec 309.25 -1.92%
09 Dec 306.00 0.07%

Sastasundar Ventures Limited Graph

Sastasundar Ventures Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sastasundar Ventures Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 316.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 314.10 317.24 285.52 - 348.97
320.38 256.31 - 384.46
323.52 226.47 - 420.58
Bearish Scenario 314.10 310.96 279.86 - 342.05
307.82 246.25 - 369.38
304.68 213.27 - 396.08

Overview of Sastasundar Ventures Limited

ISIN

INE019J01013

Industry

Medical - Pharmaceuticals

Vol.Avg

17,790

Market Cap

10,044,165,375

Last Dividend

0

Official Website

Visit Website

IPO Date

2010-10-05

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of SASTASUNDR

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2012-07-23 July 23, 12 1 1 2012-07-24 2012-09-02 2012-05-23
2011-07-25 July 25, 11 1 1 2011-07-26 2011-09-03 2011-05-27

Stock Rating Details for SASTASUNDR

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,089.53 Cr 1,017.41 Cr 72.12 Cr 0.0662 0.00 Cr 5.16 Cr -83.28 Cr -91.17 Cr -28.66 -186.82 Cr -0.0837
2024-03-31 1,356.07 Cr 1,236.12 Cr 119.95 Cr 0.0885 0.00 Cr 5.43 Cr -22.96 Cr 8.88 Cr 2.79 -20.35 Cr 0.0066
2023-03-31 1,038.19 Cr 967.03 Cr 71.15 Cr 0.0685 0.02 Cr 4.00 Cr -51.44 Cr -72.21 Cr -22.70 -113.19 Cr -0.0696
2022-03-31 629.80 Cr 585.26 Cr 44.53 Cr 0.0707 0.00 Cr 3.82 Cr -52.66 Cr 626.81 Cr 197.04 1,122.12 Cr 0.9952
2021-03-31 545.77 Cr 494.44 Cr 51.33 Cr 0.0940 0.00 Cr 2.58 Cr -19.61 Cr -10.40 Cr -3.27 -10.96 Cr -0.0191

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 12.42 Cr 974.37 Cr 109.84 Cr 669.8710 Cr 1.19 Cr -11.23 Cr 110.29 Cr 73.60 Cr 0.00 Cr 0.00 Cr 676.65 Cr 64.1597 Cr
2024-03-31 33.61 Cr 1,149.59 Cr 150.06 Cr 762.3745 Cr 3.88 Cr -29.72 Cr 115.79 Cr 71.96 Cr 0.00 Cr 1.47 Cr 792.56 Cr 52.2929 Cr
2023-03-31 31.72 Cr 1,205.82 Cr 212.26 Cr 753.4004 Cr 9.33 Cr -22.40 Cr 180.83 Cr 69.12 Cr 0.00 Cr 0.00 Cr 426.01 Cr 89.1784 Cr
2022-03-31 13.01 Cr 1,277.80 Cr 183.57 Cr 826.5021 Cr 1.85 Cr -11.15 Cr 113.53 Cr 57.58 Cr 0.00 Cr 0.00 Cr 800.73 Cr 57.9452 Cr
2021-03-31 12.04 Cr 292.81 Cr 63.43 Cr 199.8966 Cr 15.20 Cr 3.16 Cr 77.18 Cr 57.90 Cr 0.00 Cr 0.00 Cr 53.03 Cr 52.0140 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -17.3086 Cr -1.1341 Cr -0.4431 Cr -27.6652 Cr -18.8858 Cr 12.4215 Cr -10.3566 Cr -203.6650 Cr -0.3826 Cr 0.0000 Cr 5.5004 Cr
2024-03-31 38.1653 Cr -33.9275 Cr -2.3515 Cr 23.9339 Cr 1.8863 Cr 33.6077 Cr -14.2314 Cr -30.4984 Cr -2.2955 Cr 0.0000 Cr 65.0371 Cr
2023-03-31 -111.9685 Cr 132.5176 Cr -1.8332 Cr -131.4558 Cr 18.7159 Cr 31.7214 Cr -19.4873 Cr -122.2510 Cr -1.8075 Cr 0.0000 Cr -67.2983 Cr
2022-03-31 -207.1552 Cr 219.5411 Cr -11.4222 Cr -211.8853 Cr 0.9637 Cr 13.0055 Cr -4.7301 Cr 1,109.4838 Cr -9.7860 Cr 0.0000 Cr -36.3522 Cr
2021-03-31 -30.5078 Cr 21.3711 Cr 3.7256 Cr -31.4923 Cr -5.4111 Cr 12.0418 Cr -0.9845 Cr -16.3668 Cr 4.7747 Cr 0.0000 Cr -0.0948 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 309.01 Cr 285.00 Cr 24.01 Cr 0.0777 -16.26 Cr -12.69 Cr -3.99 -17.27 Cr -0.0411
2025-06-30 278.74 Cr 257.60 Cr 21.14 Cr 0.0759 -14.80 Cr 23.91 Cr 7.52 31.44 Cr 0.0858
2025-03-31 282.13 Cr 265.30 Cr 16.83 Cr 0.0597 -30.24 Cr 13.67 Cr 4.30 -3.28 Cr 0.0485
2024-12-31 280.12 Cr 263.04 Cr 17.08 Cr 0.0610 -26.30 Cr -26.94 Cr -8.47 -37.76 Cr -0.0962
2024-09-30 264.09 Cr 246.36 Cr 17.73 Cr 0.0672 -15.63 Cr -109.41 Cr -34.40 -172.12 Cr -0.4143

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 23.98 Cr 0.03 Cr 24.01 Cr 19.59 Cr 113.83 Cr 165.76 Cr 78.87 Cr 1,008.01 Cr 131.75 Cr
2025-06-30 0.00 Cr 0.00 Cr 12.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -864.53 Cr
2025-03-31 12.42 Cr 0.02 Cr 12.44 Cr 18.97 Cr 110.29 Cr 148.92 Cr 73.60 Cr 974.37 Cr 109.84 Cr
2024-12-31 0.00 Cr 0.00 Cr 25.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -892.04 Cr
2024-09-30 25.01 Cr 0.07 Cr 25.08 Cr 33.30 Cr 106.56 Cr 170.39 Cr 65.83 Cr 1,004.74 Cr 112.70 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 23.91 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 13.67 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -26.94 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -109.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 31.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹820.05 ₹98,215,499,105.00 ₹35,302.00

Key Executives

Chairman, MD & Chief Executive Officer
Banwari Lal Mittal

Gender: male

Year Born: 1968

Chief Financial Officer
Lokesh Agarwal

Gender: male

Year Born: 1986

Company Secretary & Compliance Officer
Pratap Singh

Gender: male

Year Born: 1987

Manager of Accounts
Subir Basu

Gender: Not Specified

Year Born: 1969

FAQs about Sastasundar Ventures Limited

Who is the CEO of the company?

The CEO is Banwari Lal Mittal.

What is the current market price of the stock?

The current price is ₹315.75.

What is the 52-week price range?

The range is ₹205-342.

What is the market capitalization of the company?

The market capitalization is ₹1,004.42 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -490.94.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sastasundar Ventures Limited (ISIN: INE019J01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,004.42 crores and an average daily volume of 17,790 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.